Bristol Myers Squibb (BMY) Change in Inventory (2016 - 2025)
Historic Change in Inventory for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $90.0 million.
- Bristol Myers Squibb's Change in Inventory fell 5871.56% to $90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year decrease of 9067.6%. This contributed to the annual value of $486.0 million for FY2024, which is 3528.63% down from last year.
- As of Q3 2025, Bristol Myers Squibb's Change in Inventory stood at $90.0 million, which was down 5871.56% from -$4.0 million recorded in Q2 2025.
- Over the past 5 years, Bristol Myers Squibb's Change in Inventory peaked at $282.0 million during Q1 2023, and registered a low of -$175.0 million during Q4 2024.
- Over the past 5 years, Bristol Myers Squibb's median Change in Inventory value was $41.0 million (recorded in 2022), while the average stood at $81.5 million.
- In the last 5 years, Bristol Myers Squibb's Change in Inventory surged by 2830000.0% in 2023 and then plummeted by 18883.25% in 2024.
- Over the past 5 years, Bristol Myers Squibb's Change in Inventory (Quarter) stood at $128.0 million in 2021, then tumbled by 67.97% to $41.0 million in 2022, then skyrocketed by 380.49% to $197.0 million in 2023, then tumbled by 188.83% to -$175.0 million in 2024, then skyrocketed by 151.43% to $90.0 million in 2025.
- Its Change in Inventory was $90.0 million in Q3 2025, compared to -$4.0 million in Q2 2025 and $169.0 million in Q1 2025.